DK3668856T3 - Hidtil ukendte tetrazolforbindelser og anvendelse deraf til behandling af tuberkulose - Google Patents
Hidtil ukendte tetrazolforbindelser og anvendelse deraf til behandling af tuberkulose Download PDFInfo
- Publication number
- DK3668856T3 DK3668856T3 DK18755815.0T DK18755815T DK3668856T3 DK 3668856 T3 DK3668856 T3 DK 3668856T3 DK 18755815 T DK18755815 T DK 18755815T DK 3668856 T3 DK3668856 T3 DK 3668856T3
- Authority
- DK
- Denmark
- Prior art keywords
- tuberculosis
- treatment
- tetrazole compounds
- novel tetrazole
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
- C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17382574 | 2017-08-17 | ||
| PCT/EP2018/072205 WO2019034729A1 (en) | 2017-08-17 | 2018-08-16 | NOVEL TETRAZOLE COMPOUNDS AND THEIR USE IN THE TREATMENT OF TUBERCULOSIS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3668856T3 true DK3668856T3 (da) | 2021-09-20 |
Family
ID=59713960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18755815.0T DK3668856T3 (da) | 2017-08-17 | 2018-08-16 | Hidtil ukendte tetrazolforbindelser og anvendelse deraf til behandling af tuberkulose |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US11072591B2 (da) |
| EP (1) | EP3668856B1 (da) |
| JP (1) | JP7410017B2 (da) |
| KR (1) | KR102661367B1 (da) |
| CN (1) | CN110997651B (da) |
| AU (1) | AU2018317812C1 (da) |
| BR (1) | BR112020003247A2 (da) |
| CA (1) | CA3072854A1 (da) |
| CY (1) | CY1124577T1 (da) |
| DK (1) | DK3668856T3 (da) |
| ES (1) | ES2885573T3 (da) |
| HR (1) | HRP20211326T1 (da) |
| HU (1) | HUE055732T2 (da) |
| LT (1) | LT3668856T (da) |
| PL (1) | PL3668856T3 (da) |
| PT (1) | PT3668856T (da) |
| RS (1) | RS62267B1 (da) |
| SI (1) | SI3668856T1 (da) |
| WO (1) | WO2019034729A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111184718A (zh) * | 2018-11-15 | 2020-05-22 | 鲁南制药集团股份有限公司 | 法罗培南在制备治疗初治病原学阳性肺结核药物中的用途 |
| CN115403533B (zh) * | 2021-05-28 | 2023-08-25 | 永康市第一人民医院 | 一种1-苯乙烯基-1,2,3-三氮唑化合物及其制备方法和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3621427B2 (ja) * | 1997-07-22 | 2005-02-16 | 塩野義製薬株式会社 | 糸球体障害治療または予防剤 |
| JP2010523599A (ja) * | 2007-04-05 | 2010-07-15 | シーメンス メディカル ソリューションズ ユーエスエー インコーポレイテッド | クリックケミストリーを使用した炭酸脱水酵素−ｉｘのための分子イメージングプローブの開発 |
| WO2017066964A1 (en) * | 2015-10-22 | 2017-04-27 | Merck Sharp & Dohme Corp. | Oxazolidinone compounds and methods of use thereof as antibacterial agents |
-
2018
- 2018-08-16 EP EP18755815.0A patent/EP3668856B1/en active Active
- 2018-08-16 PT PT187558150T patent/PT3668856T/pt unknown
- 2018-08-16 JP JP2020508427A patent/JP7410017B2/ja active Active
- 2018-08-16 US US16/639,163 patent/US11072591B2/en active Active
- 2018-08-16 DK DK18755815.0T patent/DK3668856T3/da active
- 2018-08-16 HU HUE18755815A patent/HUE055732T2/hu unknown
- 2018-08-16 BR BR112020003247-6A patent/BR112020003247A2/pt unknown
- 2018-08-16 SI SI201830348T patent/SI3668856T1/sl unknown
- 2018-08-16 KR KR1020207007186A patent/KR102661367B1/ko active IP Right Grant
- 2018-08-16 CN CN201880053320.XA patent/CN110997651B/zh active Active
- 2018-08-16 WO PCT/EP2018/072205 patent/WO2019034729A1/en unknown
- 2018-08-16 CA CA3072854A patent/CA3072854A1/en active Pending
- 2018-08-16 AU AU2018317812A patent/AU2018317812C1/en active Active
- 2018-08-16 PL PL18755815T patent/PL3668856T3/pl unknown
- 2018-08-16 RS RS20211076A patent/RS62267B1/sr unknown
- 2018-08-16 ES ES18755815T patent/ES2885573T3/es active Active
- 2018-08-16 LT LTEPPCT/EP2018/072205T patent/LT3668856T/lt unknown
-
2021
- 2021-08-17 HR HRP20211326TT patent/HRP20211326T1/hr unknown
- 2021-08-31 CY CY20211100770T patent/CY1124577T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR102661367B1 (ko) | 2024-04-29 |
| EP3668856B1 (en) | 2021-06-23 |
| AU2018317812A1 (en) | 2020-02-20 |
| AU2018317812C1 (en) | 2021-08-26 |
| RU2020110818A (ru) | 2021-09-17 |
| SI3668856T1 (sl) | 2021-11-30 |
| PL3668856T3 (pl) | 2021-12-13 |
| US20200231555A1 (en) | 2020-07-23 |
| JP7410017B2 (ja) | 2024-01-09 |
| HRP20211326T1 (hr) | 2021-11-26 |
| JP2020531425A (ja) | 2020-11-05 |
| RS62267B1 (sr) | 2021-09-30 |
| CN110997651B (zh) | 2023-01-03 |
| KR20200041915A (ko) | 2020-04-22 |
| CA3072854A1 (en) | 2019-02-21 |
| BR112020003247A2 (pt) | 2020-08-18 |
| AU2018317812B2 (en) | 2021-04-15 |
| PT3668856T (pt) | 2021-09-15 |
| EP3668856A1 (en) | 2020-06-24 |
| LT3668856T (lt) | 2021-09-27 |
| WO2019034729A1 (en) | 2019-02-21 |
| CN110997651A (zh) | 2020-04-10 |
| RU2020110818A3 (da) | 2021-10-11 |
| US11072591B2 (en) | 2021-07-27 |
| HUE055732T2 (hu) | 2021-12-28 |
| CY1124577T1 (el) | 2022-07-22 |
| ES2885573T3 (es) | 2021-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3678668T3 (da) | ENPP1-inhibitorer og deres anvendelse til behandling af kræft | |
| DK3448386T3 (da) | Isoquinolin-3-ylcarboxamider og fremstilling og anvendelse deraf | |
| DK3658557T3 (da) | Tyk2-inhibitorer og anvendelser deraf | |
| DK3445388T3 (da) | Materialer og fremgangsmåder til behandling af hæmoglobinopatier | |
| DK3578547T3 (da) | Sulfonylureaer og relaterede forbindelser og brug af samme | |
| DK3303396T5 (da) | Antistoffer mod ox40 og anvendelser deraf | |
| DK3283106T3 (da) | Terapeutiske antistoffer og anvendelser deraf | |
| DK3303379T3 (da) | Tigit-bindende midler og anvendelser deraf | |
| DK3877376T3 (da) | Pyridazinonforbindelser og anvendelser deraf | |
| DK3842429T3 (da) | Heterocykliske inhibitorer af ERK1 og ERK2 og anvendelse deraf i behandling af cancer | |
| DK3610005T3 (da) | Peptidligase og anvendelse deraf | |
| DK3877052T3 (da) | Pyridazinonforbindelser og anvendelser deraf | |
| DK3357513T3 (da) | Farmaceutisk sammensætning og anvendelse deraf | |
| DK3621694T5 (da) | Lrrc33-inhibitorer og anvendelse heraf | |
| DK3242947T3 (da) | Genterapi og elektroporese til behandling af maligniteter | |
| DK2994157T3 (da) | Tafa4-forbindelser og anvendelser deraf til behandling af smerte | |
| DK3474883T3 (da) | Komplementinhibitorer og anvendelser deraf | |
| DK3790879T3 (da) | Triazolopyrimidinforbindelser og deres anvendelse til behandling af kræft | |
| DK3522873T3 (da) | Sammensætninger og fremgangsmåder til behandlingen af xerostomi | |
| DK3615502T3 (da) | Terapeutiske forbindelser og fremgangsmåder | |
| DK3321279T3 (da) | Exenatidmodificeringsmiddel og anvendelse deraf | |
| DK3373922T3 (da) | Sammensætninger og fremgangsmåder til anvendelse i behandlingen af homocystinuri | |
| DK3668856T3 (da) | Hidtil ukendte tetrazolforbindelser og anvendelse deraf til behandling af tuberkulose | |
| DK3573611T3 (da) | Amidforbindelser og anvendelse deraf | |
| DK3512544T3 (da) | Peptidforbindelser og terapeutiske anvendelser deraf |